Article Versions Notes

Yamamoto S, Sakai Y, Matsumori K, Osawa R, Ito S, Tsukakoshi D, Ohno T, Ohta H, Ichiyama T, Komatsu M, et al. Clinical Outcomes and Prevalence of Sarcopenia in Patients with Moderate to Severe COVID-19. Journal of Clinical Medicine. 2022; 11(21):6578. https://doi.org/10.3390/jcm11216578

Yamamoto, Shuhei, Yasunari Sakai, Keiji Matsumori, Ryuji Osawa, Shun Ito, Daichi Tsukakoshi, Tomoki Ohno, Hiroaki Ohta, Takashi Ichiyama, Masamichi Komatsu, and et al. 2022. "Clinical Outcomes and Prevalence of Sarcopenia in Patients with Moderate to Severe COVID-19" Journal of Clinical Medicine 11, no. 21: 6578. https://doi.org/10.3390/jcm11216578

Yamamoto, S., Sakai, Y., Matsumori, K., Osawa, R., Ito, S., Tsukakoshi, D., Ohno, T., Ohta, H., Ichiyama, T., Komatsu, M., Wada, Y., Hanaoka, M., Ikegami, S., & Horiuchi, H. (2022). Clinical Outcomes and Prevalence of Sarcopenia in Patients with Moderate to Severe COVID-19. Journal of Clinical Medicine, 11(21), 6578. https://doi.org/10.3390/jcm11216578